Mersana Therapeutics Inc (MRSN)
1.96
+0.12
(+6.52%)
USD |
NASDAQ |
Nov 05, 14:37
Mersana Therapeutics Shareholders Equity (Quarterly): 8.427M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 8.427M |
| March 31, 2024 | 27.98M |
| December 31, 2023 | 36.90M |
| September 30, 2023 | 52.20M |
| June 30, 2023 | 89.80M |
| March 31, 2023 | 64.29M |
| December 31, 2022 | 92.06M |
| September 30, 2022 | 90.23M |
| June 30, 2022 | 134.03M |
| March 31, 2022 | 140.53M |
| December 31, 2021 | 121.74M |
| September 30, 2021 | 155.55M |
| June 30, 2021 | 195.51M |
| March 31, 2021 | 197.94M |
| December 31, 2020 | 228.09M |
| September 30, 2020 | 253.31M |
| Date | Value |
|---|---|
| June 30, 2020 | 273.56M |
| March 31, 2020 | 63.09M |
| December 31, 2019 | 78.32M |
| September 30, 2019 | 93.04M |
| June 30, 2019 | 108.51M |
| March 31, 2019 | 124.07M |
| December 31, 2018 | 8.795M |
| September 30, 2018 | 29.85M |
| June 30, 2018 | 45.69M |
| March 31, 2018 | 56.55M |
| December 31, 2017 | 69.99M |
| September 30, 2017 | 83.64M |
| June 30, 2017 | -71.66M |
| March 31, 2017 | 31.14M |
| December 31, 2016 | -55.62M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
8.427M
Minimum
Jun 2024
273.56M
Maximum
Jun 2020
121.24M
Average
92.06M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Chimerix Inc | 155.58M |
| Cellectar Biosciences Inc | 12.38M |
| Marinus Pharmaceuticals Inc | -47.34M |
| Jaguar Health Inc | 16.91M |
| Seres Therapeutics Inc | -87.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 179.13M |
| Total Liabilities (Quarterly) | 170.70M |
| Debt to Equity Ratio | 3.012 |
| Current Ratio | 2.717 |
| Net Debt Paydown Yield | -0.03% |